COVID-19 Treatments 2022 Forecast: Revenue, Supply and Demand
Download Airfinity's latest projections on COVID-19 oral antivirals
The report includes a breakdown of forecasted revenue for Molnupiravir and Paxlovid in the US, EU(including UK) and ROW, as well as the current outlook on supply and demand trends for COVID-19 treatments.
The report includes a breakdown of forecasted revenue for Molnupiravir and Paxlovid in the US, EU(including UK) and ROW, as well as the current outlook on supply and demand trends for COVID-19 treatments.
For press enquiries, please contact press@airfinity.com